TGFB1 and prostate cancer: Using a transgenic SV 40 T-antigen-driven mouse prostate model with a dominant negative TβRII mutant receptor, it was reported that disruption of the TGFβ signaling promoted prostate cancer metastasis to the lymph node, lungs, and liver [179].